slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 226,741-226,770
Pages 10,126
Rows per page 30
Component
226,741-226,770 of 303,780
28
The table displays n (%) for categorical variables and descriptive statistics (mean, SD, median, range) for age.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
29
MAD likely stands for Multiple Ascending Dose.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
32
Larimar Therapeutics | Investor Presentation Deck | 44 slidesLarimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
33
The slide outlines a 28-day treatment schedule with specific administration days highlighted in green.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
36
The slide highlights that demographics are similar between Phase 1 and Phase 2 trials.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
37
Data presented as n, mean (SD), median, Q1/Q3, and min/max.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
39
Larimar Therapeutics | Investor Presentation Deck | 44 slidesLarimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
40
Kaplan-Meier survival curve showing efficacy of FXN replacement therapy.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
42
Includes two charts: a bar chart for hFXN concentration and a dot plot with error bars for SDH activity.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
43
Data shows significant differences (****) between vehicle and CTI-1601 treated KO mice.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
44
The slide uses two line charts to demonstrate efficacy in two different cardiac metrics (Ejection Function and Fractional Shortening) over an 8-week period.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
02
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Attention1 hit
03
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Attention1 hit
04
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Need1 hit
05
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
06
The slide outlines a deal structure involving upfront payments, milestones, royalties, and a division of development labor.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
07
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
08
The chart shows a stacked bar breakdown of U.S. vs EU sales over 6 quarters.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
The slide uses a grid-based layout to organize clinical trials by stage and therapeutic focus.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
10
The slide uses bar charts to compare year-over-year performance, highlighting percentage changes.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
11
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
13
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Action1 hit
14
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Action1 hit
15
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Action1 hit
02
Standard SEC-style safe-harbor disclaimer placed near the front of the deck; mostly dense body text with Lenovo branding in the footer.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Setup1 hit
05
Includes footnotes regarding non-PC revenue and non-HKFRS measures.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
06
Includes financial performance indicators and credit rating update.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
07
Includes performance metrics for Q2 22/23 through Q2 23/24.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
08
Includes performance charts for revenue and operating profit/margin, plus market position callouts.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
09
Includes quarterly revenue and operating profit trends, plus key strategic metrics.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit